Cancer treatment-induced bone loss (CTIBL): pathogenesis and clinical implications.
about
The role of biomarkers in the management of bone-homing malignancies.ACVR2B/Fc counteracts chemotherapy-induced loss of muscle and bone mass.Cyclophosphamide causes osteoporosis in C57BL/6 male mice: suppressive effects of cyclophosphamide on osteoblastogenesis and osteoclastogenesis.Suppressing angiogenesis regulates the irradiation-induced stimulation on osteoclastogenesis in vitro.Cancer Treatment and Bone Health.Impact of physical exercise in cancer survivors during and after antineoplastic treatments.PTH(1-34) and zoledronic acid have differing longitudinal effects on juvenile mouse femur strength and morphology.PTH1R-CaSR Cross Talk: New Treatment Options for Breast Cancer Osteolytic Bone Metastases
P2860
Q41692580-EE6AF092-EDBA-499C-BF83-968354C54A9EQ45219853-2D588F06-10EA-4025-AF4F-0F70EA46A7CDQ47104810-3C102BEF-7455-4DF3-81D2-DDB5BCB18700Q48300733-6AE6FE49-667A-4E7D-85F2-F4CD22351FDDQ49211720-EB7D226C-66C0-4281-AE31-EA66BCEB56F9Q51732172-27BF6288-1142-4D6C-88A9-1662F3B265FEQ51800119-FA5548AA-A2A6-4BC2-A98A-DD4651A9F0D0Q57109145-539E2E2B-420E-4080-9010-08D2498CA8A0
P2860
Cancer treatment-induced bone loss (CTIBL): pathogenesis and clinical implications.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cancer treatment-induced bone loss (CTIBL): pathogenesis and clinical implications.
@en
type
label
Cancer treatment-induced bone loss (CTIBL): pathogenesis and clinical implications.
@en
prefLabel
Cancer treatment-induced bone loss (CTIBL): pathogenesis and clinical implications.
@en
P2093
P50
P1476
Cancer treatment-induced bone loss (CTIBL): pathogenesis and clinical implications
@en
P2093
F Silvestris
S D'Oronzo
P304
P356
10.1016/J.CTRV.2015.09.003
P577
2015-09-15T00:00:00Z